Next step in national consumables centralized procurement with volume, finalized!
8 kinds of high value consumables, average price reduction of more than 80%
Shi Zihai, deputy director of the National Healthcare Security Administration, said that for a long time, the prices of medicines and high-value medical supplies have been artificially high in China, especially some “imported old drugs”. Although they have passed the patent period, they are still sold at a higher price in China, and the prices of high-value medical supplies are far higher than the international level.
In response to this situation, the National Heatthcare Security Administration, together with relevant departments, actively promotes the centralized procurement of drugs and high-value medical consumables, and achieves price reduction of selected products by reducing the production and marketing costs of selected enterprises.
The focus of the fourth batch of national centralized procurement and inter-provincial alliances.
At this press conference, the relevant person in charge of the National Healthcare Security Bureau also introduced the future centralized procurement plan.
The Deputy Director of the National Healthcare Security Bureau, Shi Zihai, pointed out that in the next step, we will continue to promote the expansion of the scope of centralized procurement with volume, with national and local linkage and integrated promotion. At the national level, the fourth batch of centralized procurement with volume of high-value medical consumables will be carried out, mainly for intraocular lens in ophthalmology and sports medicine consumables in orthopaedics.
At the local level, it will focus on the procurement of neurosurgery consumables, in vitro diagnostic reagents, etc., which are not centralized procurement of the national organization. At the same time, it will further strengthen the quality control and supply guarantee of the products collected by the national organization, promote medical institutions to give priority to the procurement and use of the selected products, and ensure that the people really enjoy the results of the reform.
China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com
Source：Saibolan Device
Translated & edited ： Bradyknows
